Controlled aggregation of ferritin to modulate MRI relaxivity

Biophysical Journal

Volumn 95, Issue 1, 2008, Pages 342-351

  Bennett, Kevin M ^a   Shapiro, Erik M ^b   Sotak, Christopher H ^c,d   Koretsky, Alan P ^a,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b YALE UNIVERSITY   (United States)

^c WORCESTER POLYTECHNIC INSTITUTE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRITIN;

ARTICLE; CHEMISTRY; IMAGE ENHANCEMENT; IMAGE QUALITY; INSTRUMENTATION; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REPORTER GENE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; FERRITINS; GENES, REPORTER; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; PHANTOMS, IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 46749115145     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.107.116145     Document Type: Article

References (39)

1. Geninatti, C. S., A. Barge, E. Battistini, C. Cabella, S. Coluccia, D. Longo, V. Mainero, G. Tarone, and S. Aime. 2005. Magnetic resonance imaging visualization of targeted cells by the internalization of supramolecular adducts formed between avidin and biotinylated Gd3+ chelates. J. Biol. Inorg. Chem. 10:78-86.
2. Zhang, S., M. Merritt, D. E. Woessner, R. E. Lenkinski, and A. D. Sherry. 2003. PARACEST agents: modulating MRI contrast via water proton exchange. Acc. Chem. Res. 36:783-790.
3. Louie, A. Y., M. M. Huber, E. T. Ahrens, U. Rothbacher, R. Moats, R. E. Jacobs, S. E. Fraser, and T. J. Meade. 2000. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 18:321-325.
4. Josephson, L., M. F. Kircher, U. Mahmood, Y. Tang, and R. Weissleder. 2002. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug. Chem. 13:554-560.
5. Lowe, M. P. 2004. Activated MR contrast agents. Curr. Pharm. Biotechnol. 5:519-528.
6. Xia, M., V. Kodibagkar, H. Liu, and R. P. Mason. 2006. Tumour oxygen dynamics measured simultaneously by near-infrared spectroscopy and 19F magnetic resonance imaging in rats. Phys. Med. Biol. 51:45-60.
7. Gilad, A. A., P. T. Winnard, Jr., P. C. van Zijl, and J. W. Bulte. 2007. Developing MR reporter genes: promises and pitfalls. NMR Biomed. 20:275-290.
8. Gottesfeld, Z., and M. Neeman. 1996. Ferritin effect on the transverse relaxation of water: NMR microscopy at 9.4T. Magn. Reson. Med. 35:514-520.
9. Cohen, B., H. Dafni, G. Meir, A. Harmelin, and M. Neeman. 2005. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia. 7:109-117.
10. Genove, G., U. DeMarco, H. Xu, W. F. Goins, and E. T. Ahrens. 2005. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 11:450-454.
11. Deans, A. E., Y. Z. Wadghiri, L. M. Bernas, X. Yu, B. K. Rutt, and D. H. Turnbull. 2006. Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn. Reson. Med. 56:51-59.
12. Gossuin, Y., R. N. Muller, P. Gillis, and L. Bartel. 2005. Relaxivities of human liver and spleen ferritin. Magn. Reson. Imaging. 23:1001-1004.
13. Chasteen, N. D., and P. M. Harrison. 1999. Mineralization in ferritin: an efficient means of iron storage. J. Struct. Biol. 126:182-194.
14. 3+ core ions. Magn. Reson. Med. 3:755-767.
15. Bulte, J. M., J. Vymazal, R. A. Brooks, C. Pierpaoli, and J. A. Frank. 1993. Frequency dependence of MR relaxation times. II. Iron oxides. J. Magn. Reson. Imaging. 3:641-648.
16. Hilty, S., B. Webb, R. B. Frankel, and G. D. Watt. 1994. Iron core formation in horse spleen ferritin: magnetic susceptibility, pH, and compositional studies. J. Inorg. Biochem. 56:173-185.
17. Brooks, R. A., J. Vymazal, R. B. Goldfarb, J. M. Bulte, and P. Aisen. 1998. Relaxometry and magnetometry of ferritin. Magn. Reson. Med. 40:227-235.
18. Gossuin, Y., A. Roch, R. N. Muller, P. Gillis, and F. Lo Bue. 2002. Anomolous nuclearmagnetic relaxation of aqueous solutions of ferritin: an unprecedented first-order mechanism. Magn. Reson. Med. 48:959-964.
19. Stark, D. D., N. M. Bass, A. A. Moss, B. R. Bacon, J. H. McKerrow, C. E. Cann, A. Brito, and H. I. Goldberg. 1983. Nuclear magnetic resonance imaging of experimentally induced liver disease. Radiology. 148:743-751.
20. Gossuin, Y., C. Burtea, A. Monseux, G. Toubeau, A. Roch, R. N. Muller, and P. Gillis. 2004. Ferritin-induced relaxation in tissues: an in vitro study. J. Magn. Reson. Imaging. 20:690-696.
21. Meldrum, F. C., B. R. Heywood, and S. Mann. 1992. Magnetoferritin: in vitro synthesis of a novel magnetic protein. Science. 257:522-523.
22. Bulte, J. W., T. Douglas, S. Mann, R. B. Frankel, B. M. Moskowitz, R. A. Brooks, C. D. Baumgarner, J. Vymazal, M. P. Strub, and J. A. Frank. 1994. Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent. J. Magn. Reson. Imaging. 4:497-505.
23. Weisskoff, R. M., C. S. Zuo, J. L. Boxerman, and B. R. Rosen. 1994. Microscopic susceptibility variation and transverse relation: theory and experiment. Magn. Reson. Med. 31:601-610.
24. Jensen, J. H., and R. Chandra. NMR relaxation in tissues with weak magnetic inhomogeneities.2000. Magn Reson Med. 44:144-156.
25. Jensen, J. H., R. Chandra, and H. Yu. 2001. Quantitative model for the interecho time dependence of the CPMG relaxation rate in iron-rich gray matter. Magn. Reson. Med. 46:159-165.
26. Wood, J. C., J. D. Fassler, and T. Meade. 2004. Mimicking liver iron overload using liposomal ferritin preparations. Magn. Reson. Med. 51:607-611.
27. Frank, S., and P. C. Lauterbur. 1993. Voltage-sensitive magnetic gels as magnetic resonance monitoring agents. Nature. 363:334-336.
28. Bogdanov, A., Jr., L. Matuszewski, C. Bremer, A. Petrovsky, and R. Weissleder. 2002. Oligomerization of paramagnetic substrates results in signal amplification and can be used for MR imaging of molecular targets. Mol. Imaging. 1:16-23.
29. Steinmetz, M. O., K. N. Goldie, and U. Aebi. 1997. A correlative analysis of actin filament assembly, structure, and dynamics. J. Cell Biol. 138:559-574.
30. Goldmann, W. H. 2002. Examination of actin polymerization and viscosity induced by cations and ionic strength when cross-linked by alpha-actinin. Cell Biol. Int. 26:541-546.
31. Lange, K., and J. Gartzke. 2006. F-actin-based Ca signaling - a critical comparison with the current concept of Ca signaling. J. Cell. Physiol. 209:270-287.
32. Nusco, G. A., J. T. Chun, E. Ercolano, D. Lim, G. Gragnaniello, K. Kyozuka, and L. Santella. 2006. Modulation of calcium signaling by the actin-binding protein cofilin. Biochem. Biophys. Res. Commun. 348:109-114.
33. Atanasijevic, T., M. Shusteff, P. Fam, and A. Jasanoff. 2006. Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin. Proc. Natl. Acad. Sci. USA. 103:14707-14712.
34. Danon, D., L. Goldstein, Y. Marikovsky, and E. Skutelsky. 1972. Use of cationized ferritin as a label of negative charges on cell surfaces. J. Ultrastruct. Res. 38:500-510.
35. Mikawa, M., H. Kato, M. Okumura, M. Narazaki, Y. Kanazawa, N. Miwa, and H. Shinohara. 2001. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug. Chem. 12:510-514.
36. Bogdanov, A. A., C. Martin, R. Weissleder, and T. J. Brady. 1994. Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid: preparation of ferrosomes. Biochim. Biophys. Acta. 1193:212-218.
37. Wunderbaldinger, P., L. Josephson, and R. Weissleder. 2002. Cross-linked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad. Radiol. 9(Suppl. 2):304-306.
38. Josephson, L., M. F. Kircher, U. Mahmood, Y. Tang, and R. Weissleder. 2002. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug. Chem. 13:554-560.
39. Merriam, R. W., and T. G. Clark. 1978. Actin in Xenopus oocytes. II. Intracellular distribution and polymerizability. J Cell Biol. 77: 439-447.